Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) – A Case Report - Hass, H G; Denzlinger, C (Zeitschrift für Gastroenterologie, 2009)